SITC 26th annual meeting--summary.

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• The 26th annual meeting of the Society for Immunotherapy of Cancer (SITC) convened in Bethesda, MD, November 4-6, 2011.
• The event saw record attendance, drawing 805 participants from 24 countries.
• The meeting occurred during a period of significant developments in tumor immunology.

Framework:

• Key developments included the approval of anti-CTLA-4 therapy for metastatic melanoma.
• The Nobel Prize in Physiology or Medicine was awarded for fundamental discoveries in immunology.
• Honorees included Bruce Beutler and Jules Hoffman for innate immunity research, and Ralph Steinman for dendritic cell discovery.

Implementation:

• The meeting featured presentations from leading researchers in the field of cancer immunotherapy.
• Discussions likely focused on the latest advancements and future directions in the rapidly evolving field.
• The event served as a platform for knowledge exchange and networking among global experts.

Implications:

• The confluence of therapeutic advancements and Nobel recognition highlighted the growing importance of immunotherapy in cancer treatment.
• The meeting underscored the significant impact of basic immunology research on clinical applications.
• The passing of esteemed scientists Jürg Tschopp and Ralph Steinman cast a somber note, emphasizing the contributions and legacy of pioneers in the field.